STOCK TITAN

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Pfizer (NYSE: PFE) has announced a public webcast featuring Aamir Malik, Chief U.S. Commercial Officer and Executive Vice President, at the UBS Global Healthcare Conference on November 13, 2024, at 12:30 p.m. PST.

Investors and the public can access the webcast through www.pfizer.com/investors, where registration details are currently available. A transcript and replay will be accessible within 24 hours after the live discussion and remain available for at least 90 days.

Pfizer (NYSE: PFE) ha annunciato un webcast pubblico con Aamir Malik, Chief U.S. Commercial Officer e Vicepresidente Esecutivo, durante il UBS Global Healthcare Conference il 13 novembre 2024, alle 12:30 ora pacifica.

Gli investitori e il pubblico possono accedere al webcast tramite www.pfizer.com/investors, dove sono attualmente disponibili i dettagli per la registrazione. Una trascrizione e la registrazione saranno accessibili entro 24 ore dopo la discussione dal vivo e rimarranno disponibili per almeno 90 giorni.

Pfizer (NYSE: PFE) ha anunciado un webcast público con Aamir Malik, Director Comercial de EE. UU. y Vicepresidente Ejecutivo, en la Conferencia Global de Salud de UBS el 13 de noviembre de 2024, a las 12:30 p.m. PST.

Los inversores y el público pueden acceder al webcast a través de www.pfizer.com/investors, donde ya están disponibles los detalles de registro. Una transcripción y la repetición estarán disponibles dentro de las 24 horas posteriores a la discusión en vivo y seguirán accesibles durante al menos 90 días.

화이자 (NYSE: PFE)는 Aamir Malik 미국 상업 담당 최고 책임자 겸 부사장과 함께 UBS 글로벌 헬스케어 컨퍼런스에서 2024년 11월 13일 오후 12시 30분 PST에 공개 웹캐스트를 개최한다고 발표했습니다.

투자자와 대중은 www.pfizer.com/investors를 통해 웹캐스트에 접속할 수 있으며, 현재 등록 세부정보가 제공되고 있습니다. 생방송 후 24시간 이내에 전사본과 재생이 제공되며, 최소 90일 동안 이용 가능합니다.

Pfizer (NYSE: PFE) a annoncé un webcast public mettant en vedette Aamir Malik, directeur commercial des États-Unis et vice-président exécutif, lors de la Conférence Mondiale sur la Santé UBS le 13 novembre 2024 à 12h30 PST.

Les investisseurs et le public peuvent accéder au webcast via www.pfizer.com/investors, où les détails d'inscription sont actuellement disponibles. Une transcription et un enregistrement seront accessibles dans les 24 heures suivant la discussion en direct et resteront disponibles pendant au moins 90 jours.

Pfizer (NYSE: PFE) hat ein öffentliches Webcast mit Aamir Malik, dem Chief U.S. Commercial Officer und Executive Vice President, auf der UBS Global Healthcare Conference am 13. November 2024 um 12:30 Uhr PST angekündigt.

Investoren und die Öffentlichkeit können auf das Webcast über www.pfizer.com/investors zugreifen, wo die Registrierungsdetails derzeit verfügbar sind. Ein Transkript und eine Wiederholung werden innerhalb von 24 Stunden nach der Live-Diskussion verfügbar sein und mindestens 90 Tage lang zugänglich bleiben.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Aamir Malik, Chief U.S. Commercial Officer, Executive Vice President, at the UBS Global Healthcare Conference on Wednesday, November 13, 2024 at 12:30 p.m. PST.

To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.

The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; our anticipated operating and financial performance, including financial guidance and projections; reorganizations, business plans, strategy and prospects; strategic reviews; capital allocation objectives; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including our COVID-19 products our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Category: Finance

Media Contact:

PfizerMediaRelations@Pfizer.com

+1 (212) 733-1226



Investor Contact:

IR@Pfizer.com

+1 (212) 733-4848

Source: Pfizer Inc.

FAQ

When is Pfizer's (PFE) presentation at the UBS Global Healthcare Conference 2024?

Pfizer's presentation at the UBS Global Healthcare Conference is scheduled for Wednesday, November 13, 2024, at 12:30 p.m. PST.

Who will represent Pfizer (PFE) at the UBS Global Healthcare Conference 2024?

Aamir Malik, Pfizer's Chief U.S. Commercial Officer and Executive Vice President, will represent the company at the conference.

How can I access Pfizer's (PFE) UBS Global Healthcare Conference webcast?

The webcast can be accessed through Pfizer's investor website at www.pfizer.com/investors, where registration details are available.

How long will Pfizer's (PFE) UBS conference webcast replay be available?

The webcast replay and transcript will be available within 24 hours after the live discussion and will remain accessible for at least 90 days.

Pfizer Inc.

NYSE:PFE

PFE Rankings

PFE Latest News

PFE Stock Data

142.98B
5.66B
0.05%
67.83%
1.67%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW YORK